Can C Eye Drops Can-C eye drops are the original N-acetylcarnosine (often shorted to NAC) eye drop formula developed by the patent holders Innovative Vision Products (IVP) to reverse senile cataracts. Cataract surgery is the monly performed operation in the world with over ons in the USA alone every year. Although generally safe there is still plication rate of 30 to 50% of patients who develop opacification of the posterior lens capsule within two years and require further lazer treatment. Can-C cataract eye drops have helped thousands of people reverse their cataracts without surgery, leaving the natural lens in place rather than an artificial one. How Can-C Drops Work To Cure Cataracts Can-C contains a special analogue of the di-peptide carnosine, a naturally occurring nutrient bines two amino acids or protein fragments. This particular form is known as N-acetylcarnosine or NAC and is the main ingredient due s potency at ‘mopping up’ free radicals, the root cause of tissue damage, accelerated ageing in the body and cataracts. Cataracts are caused by the process of cross linking or glycosylation, as we age our natural anti-oxidant defense against glycosylation declines, leading to the eye lens to harden and discolour over the course of a lifetime. Other forms of carnosine are broken down by naturally occurring enzymes in the eye, but the researchers at IVP found that the N-acetylcarnosine form is highly resilient and conveys the L-carnosine directly to the aqueous humor. Once in the provides the lens proteins plete anti-oxidant protection against oxidation caused by free radicals. Human trials on people suffering from senile cataract, using a twice daily dose of Can-C for six months showed the following remarkable results: 88.9 per cent of patients had improved glare y 90 per cent reported improved visual y – clearer and sharper vision Perhaps most significantly, 41 per cent of patients experienced a significant improvement in lens y’.